Stem cells as the root of pancreatic ductal adenocarcinoma

被引:37
作者
Balic, Anamaria [1 ]
Dorado, Jorge [1 ]
Alonso-Gomez, Mercedes [1 ]
Heeschen, Christopher [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Stem Cell & Canc Grp, Clin Res Programme, Madrid 28029, Spain
关键词
Pancreatic cancer; Cancer stem cells; Tumor-initiating cells; Inflammation; Targeted therapy; CIRCULATING TUMOR-CELLS; HEDGEHOG PATHWAY; CANCER-CELLS; SIGNALING PATHWAYS; DOWN-REGULATION; MOUSE MODEL; C-MET; CXCR4; GEMCITABINE; EXPRESSION;
D O I
10.1016/j.yexcr.2011.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging evidence suggests that stem cells play a crucial role not only in the generation and maintenance of different tissues, but also in the development and progression of malignancies. For the many solid cancers, it has now been shown that they harbor a distinct subpopulation of cancer cells that bear stem cell features and therefore, these cells are termed cancer stem cells (CSC) or tumor-propagating cells. CSC are exclusively tumorigenic and essential drivers for tumor progression and metastasis. Moreover, it has been shown that pancreatic ductal adenocarcinoma does not only contain one homogeneous population of CSC rather than diverse subpopulations that may have evolved during tumor progression. One of these populations is called migrating CSC and can be characterized by CXCR4 co-expression. Only these cells are capable of evading the primary tumor and traveling to distant sites such as the liver as the preferred site of metastatic spread. Clinically even more important, however, is the observation that CSC are highly resistant to chemo- and radiotherapy resulting in their relative enrichment during treatment and rapid relapse of disease. Many laboratories are now working on the further in-depth characterization of these cells, which may eventually allow for the identification of their Achilles heal and lead to novel treatment modalities for fighting this deadly disease. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:691 / 704
页数:14
相关论文
共 50 条
  • [1] Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
    Bubin, Roman
    Uljanovs, Romans
    Strumfa, Ilze
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [2] The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma
    Melendez-Zajgla, Jorge
    Maldonado, Vilma
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [3] Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
    Karimnia, Vida
    Slack, Frank J.
    Celli, Jonathan P.
    CANCERS, 2021, 13 (17)
  • [4] Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
    Tumanskyi, V. O.
    Kovalenko, I. S.
    PATHOLOGIA, 2019, (01): : 131 - 138
  • [5] Targeting dendritic cells in pancreatic ductal adenocarcinoma
    Deicher, Anton
    Andersson, Roland
    Tingstedt, Bobby
    Lindell, Gert
    Bauden, Monika
    Ansari, Daniel
    CANCER CELL INTERNATIONAL, 2018, 18
  • [6] Role of cancer stem cells in pancreatic ductal adenocarcinoma
    Sergeant, Gregory
    Vankelecom, Hugo
    Gremeaux, Lies
    Topal, Baki
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (10) : 580 - 586
  • [7] Mast cells in pancreatic ductal adenocarcinoma
    Chang, David Z.
    ONCOIMMUNOLOGY, 2012, 1 (05): : 754 - 755
  • [8] The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma
    Krog, Ricki T.
    de Miranda, Noel F. C. C.
    Vahrmeijer, Alexander L.
    Kooreman, Nigel G.
    CANCERS, 2021, 13 (22)
  • [9] Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma
    Varillas, Jose I.
    Zhang, Jinling
    Chen, Kangfu
    Barnes, Isis I.
    Liu, Chen
    George, Thomas J.
    Fan, Z. Hugh
    THERANOSTICS, 2019, 9 (05): : 1417 - 1425
  • [10] Mast cells and angiogenesis in pancreatic ductal adenocarcinoma
    Longo, Vito
    Tamma, Roberto
    Brunetti, Oronzo
    Pisconti, Salvatore
    Argentiero, Antonella
    Silvestris, Nicola
    Ribatti, Domenico
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (03) : 319 - 323